Yun H, et al. Do Patients with Moderate or High Disease Activity Escalate RA Therapy According to Treat-to-Target Principles? Results from the ACR’s RISE Registry. ACR 2018, abstract 2856.
Hoger risico cutane reumatologische aandoeningen na SARS-CoV-2-infectie
mrt 2022 | Sclerodermie, Systemische lupus erythematodes, Vasculitis